ARDEA BIOSCIENCES, INC./DE Research and Development Expense
ARDEA BIOSCIENCES, INC./DE reported Research and Development Expense of $36.80 million for the 3-month period ending 2012-03-31, per its 10-Q filed 2012-05-07.
Discontinued › Expense Statement › Operating Expenses
us-gaap:ResearchAndDevelopmentExpense · last filed 2012-05-07
- ARDEA BIOSCIENCES, INC./DE research and development expense for the quarter ending 2012-03-31 was $36.80M, a 189.45% increase year-over-year.
- ARDEA BIOSCIENCES, INC./DE research and development expense for the quarter ending 2011-12-31 was $26.89M, a 88.21% increase year-over-year.
- ARDEA BIOSCIENCES, INC./DE research and development expense for the quarter ending 2011-09-30 was $19.29M, a 31.36% increase year-over-year.
- ARDEA BIOSCIENCES, INC./DE research and development expense for the quarter ending 2011-06-30 was $15.53M, a 20.51% increase year-over-year.
- ARDEA BIOSCIENCES, INC./DE research and development expense for fiscal 2011 was $74.42M, a 42.82% increase from fiscal 2010.
- ARDEA BIOSCIENCES, INC./DE research and development expense for fiscal 2010 was $52.11M, a 23.49% increase from fiscal 2009.
- ARDEA BIOSCIENCES, INC./DE research and development expense for fiscal 2009 was $42.20M.
| Period end | Research and Development Expense 3 month | Research and Development Expense 6 month | Research and Development Expense 9 month | Research and Development Expense 12 month |
|---|---|---|---|---|
| 2012-03-31 | $36.80M 10-Q · filed 2012-05-07 | $63.69M derived: sum of 2 quarters · filed 2012-05-07 | $82.99M derived: sum of 3 quarters · filed 2012-05-07 | $98.51M derived: sum of 4 quarters · filed 2012-05-07 |
| 2011-12-31 | $26.89M derived: 10-K 12 month − 10-Q 9 month · filed 2012-03-09 | $46.18M derived: sum of 2 quarters · filed 2012-03-09 | $61.71M derived: sum of 3 quarters · filed 2012-03-09 | $74.42M 10-K · filed 2012-03-09 |
| 2011-09-30 | $19.29M 10-Q · filed 2011-11-04 | $34.82M derived: sum of 2 quarters · filed 2011-11-04 | $47.53M 10-Q · filed 2011-11-04 | $61.82M derived: sum of 4 quarters · filed 2012-05-07 |
| 2011-06-30 | $15.53M 10-Q · filed 2011-08-05 | $28.24M 10-Q · filed 2011-08-05 | $42.53M derived: sum of 3 quarters · filed 2012-05-07 | $57.22M derived: sum of 4 quarters · filed 2012-05-07 |
| 2011-03-31 | $12.71M 10-Q · filed 2012-05-07 | $27.00M derived: sum of 2 quarters · filed 2012-05-07 | $41.69M derived: sum of 3 quarters · filed 2012-05-07 | $54.57M derived: sum of 4 quarters · filed 2012-05-07 |
| 2010-12-31 | $14.29M derived: 10-K 12 month − 10-Q 9 month · filed 2012-03-09 | $28.98M derived: sum of 2 quarters · filed 2012-03-09 | $41.86M derived: sum of 3 quarters · filed 2012-03-09 | $52.11M 10-K · filed 2012-03-09 |
| 2010-09-30 | $14.69M 10-Q · filed 2011-11-04 | $27.57M derived: sum of 2 quarters · filed 2011-11-04 | $37.82M 10-Q · filed 2011-11-04 | |
| 2010-06-30 | $12.88M 10-Q · filed 2011-08-05 | $23.14M 10-Q · filed 2011-08-05 | ||
| 2009-12-31 | $42.20M 10-K · filed 2012-03-09 |